[PDF][PDF] Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma
M Ni Chroinin, IR Greenstone, A Danish… - … Database Syst Rev, 2005 - health.utah.edu
Studies were assessed independently by two review authors for methodological quality and
data extraction. Confirmation was obtained from the trialists when possible. The primary …
data extraction. Confirmation was obtained from the trialists when possible. The primary …
[HTML][HTML] An international comparison of asthma, wheeze, and breathing medication use among children
Background There is variation in childhood asthma between countries with typically higher
prevalence in “Westernized” nations. We compared asthma, respiratory symptoms, and …
prevalence in “Westernized” nations. We compared asthma, respiratory symptoms, and …
Safety of the newer inhaled corticosteroids in childhood asthma
TL Randell, KC Donaghue, GR Ambler, CT Cowell… - Pediatric Drugs, 2003 - Springer
Inhaled corticosteroids (ICS) remain a vital part of the management of persistent asthma, but
concerns have been raised about their potential adverse effects in children. This review …
concerns have been raised about their potential adverse effects in children. This review …
Drugs associated with adverse events in children and adolescents
Objective To describe the suspected medications, types of reactions, and outcomes of
adverse events (AE s) most commonly reported to the United States Food and Drug …
adverse events (AE s) most commonly reported to the United States Food and Drug …
Guideline-defining asthma clinical trials of the national heart, lung, and blood institute's asthma clinical research network and childhood asthma research and …
LC Denlinger, CA Sorkness, VM Chinchilli… - Journal of Allergy and …, 2007 - Elsevier
Because of an increasing prevalence, morbidity, and mortality associated with asthma, the
National Heart, Lung, and Blood Institute created the Asthma Clinical Research Network and …
National Heart, Lung, and Blood Institute created the Asthma Clinical Research Network and …
Pediatric asthma: improving management to reduce cost of care
M Mellon, B Parasuraman - Journal of Managed Care Pharmacy, 2004 - jmcp.org
BACKGROUND: The economic burden of pediatric asthma is substantial, with national
annual health care costs of $3 billion. Successful clinical management of asthma in children …
annual health care costs of $3 billion. Successful clinical management of asthma in children …
Paediatric prescribing of asthma drugs in the UK: are we sticking to the guideline?
S Cohen, J Taitz, A Jaffé - Archives of disease in childhood, 2007 - adc.bmj.com
Background: Asthma guidelines should lead to improved, more rational asthma medication
prescribing. The aims of this study were to assess trends in paediatric asthma drug …
prescribing. The aims of this study were to assess trends in paediatric asthma drug …
Paediatric asthma exacerbation admissions and stringency of non‐pharmaceutical interventions: Results from a developing country
JW Alsulaiman, KA Kheirallah, MJ Ajlony… - … Journal of Clinical …, 2021 - Wiley Online Library
Background Non‐pharmaceutical interventions (NPI) mitigation measures implemented to
mitigate COVID‐19 has brought unprecedented global impact. Changes in daily living …
mitigate COVID‐19 has brought unprecedented global impact. Changes in daily living …
Adverse drug reactions of systemic antihistamines in children in the Netherlands
TW de Vries, F van Hunsel - Archives of disease in childhood, 2016 - adc.bmj.com
Background Antihistamines are used for the treatment of allergic rhinitis, allergic
conjunctivitis, chronic spontaneous urticaria and atopic eczema. Objective To study the …
conjunctivitis, chronic spontaneous urticaria and atopic eczema. Objective To study the …
Asthma control in children and adolescents: a study in clinical practice
It is well known that uncontrolled asthma should be carefully identified as it represents a risk
factor for asthma exacerbation, poor prognosis, and lung function worsening (1). The 2018 …
factor for asthma exacerbation, poor prognosis, and lung function worsening (1). The 2018 …